Clinical trial
Intra-osseous Co-transplant of Cord Blood and Mesenchymal Stromal Cells: A Feasibility Study
NCT02181478 is registered in ClinicalTrials.gov with Case Comprehensive Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intra-osseous Co-transplant of Cord Blood and Mesenchymal Stromal Cells: A Feasibility Study
- Lead sponsor
- Case Comprehensive Cancer Center
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 22, 2015
- Completion date
- February 7, 2020
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute lymphoblastic leukemia, acute myelogenous leukemia, chronic myelogenous leukemia, hodgkin lymphoma, lymphoid malignancies, myelodysplastic syndromes, myelofibrosis, refractory chronic lymphocytic leukemia, refractory hodgkin lymphoma, refractory non-hodgkin lymphoma, relapsed chronic lymphocytic leukemia, relapsed non-hodgkin lymphoma